GKOS
GKOS
NYSE · Health Care

Glaukos Corp

$131.19
+0.51 (+0.39%)
Financial Highlights (FY 2026)
Revenue
521.14M
Net Income
-192,758,802
Gross Margin
78.0%
Profit Margin
-37.0%
Rev Growth
+21.5%
D/E Ratio
0.11
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 78.0% 78.0% 35.4% 35.4%
Operating Margin -39.3% -35.4% 19.0% 20.4%
Profit Margin -37.0% -35.1% 13.1% 14.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 521.14M 428.92M 2.07B 2.02B
Gross Profit 406.33M 334.43M 732.67M 713.05M
Operating Income -204,964,387 -151,825,471 394.63M 412.42M
Net Income -192,758,802 -142,784,297 271.54M 285.63M
Gross Margin 78.0% 78.0% 35.4% 35.4%
Operating Margin -39.3% -35.4% 19.0% 20.4%
Profit Margin -37.0% -35.1% 13.1% 14.2%
Rev Growth +21.5% +21.5% +8.3% +18.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 367.49M 367.49M 2.72B 2.42B
Total Equity 3.47B 3.47B 2.33B 2.21B
D/E Ratio 0.11 0.11 1.17 1.09
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -202,103,366 -158,023,207 494.65M 536.96M
Free Cash Flow 145.62M 243.35M